The Indian pharma industry is on the rise since years now. Be it injectable companies in India or pharmaceutical exporters in India… the scenario is transforming rapidly, and for the better. The estimated pharma revenue is jumping up by around 30 per cent a year and is set to reach US$ 100 billion by 2025 in 5 years as projected by IPA (Indian Pharmaceutical Association). Ciron continues to be part of this growth story… proudly.
- Since 2013, more than 139,372 clinical case studies were carried out in around180 countries.
- Since 2000, Clinical trials increased globally by an average 28% approx. The 2013 figure was the highest ever in the history of clinical trials.
- Over INR 28,19,23,46,35,000 was spent on researching more than 2,900 compounds in the year 2013.
- Generally speaking, it takes around 11 years to 14 years to develop a drug.
- According to W.H.O, there are more than 12,000 different types of diseases and health problems in the world.
- A company loses billions of pounds if just one drug is recalled. Recall of Arthritis medication – Vioxx – costed the manufacturer INR 2,79,34,49,23,300 (a record at the time).
- Soliris, a drug to treat paroxysmal nocturnal hemoglobinuria – a rare blood disorder – costs INR 2,30,20,206 per year!
- Ribose-5-Phosphate Isomerase deficiency is the rarest disease on earth. With only one reported case.
- North America is responsible for approximately 42% of all biopharma sales while Europe comes second at about 27%.